Skip to content
OpenCapital
Get started

Korro Bio, Inc. KRRO Q4 2025 Annual earnings

Reported March 12, 2026 · Before market open

Revenue$1.3MBeat by $600.0K
EPS-$5.32Miss by $3.39
Revenue estimate$700.0K
EPS estimate-$1.93

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$214.3K
EPS estimate-$1.34

Versus estimates

Revenue

Q4 2025$1.3MBeat by $600.0K
Q3 2025$1.1MBeat by $665.0KQ2 2025$1.5MBeat by $1.1MQ1 2025$2.6MBeat by $2.1MQ4 2024$2.3M

Diluted EPS

Q1 2026-$1.69Miss by $0.09
Q4 2025-$5.32Miss by $3.39
Q3 2025-$1.92Beat by $0.69Q2 2025-$2.74Miss by $0.20Q1 2025-$2.49Beat by $0.11Q4 2024-$2.26Beat by $0.07

Ask the moment Korro Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Korro Bio, Inc. report Q4 2025 earnings?
Korro Bio, Inc. (KRRO) reported Q4 2025 earnings on March 12, 2026 before market open.
What were Korro Bio, Inc.'s Q4 2025 revenue and EPS?
Korro Bio, Inc. reported revenue of $1.3M and eps of $-5.32 for Q4 2025.
Did Korro Bio, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $700.0K by $600.0K. EPS missed the consensus estimate of $-1.93 by $3.39.
How did Korro Bio, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 42.8% from $2.3M a year earlier and eps declined 135.4% from $-2.26.
Where can I find Korro Bio, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-097575) and the 10-K periodic report (0001193125-26-104156) directly on SEC EDGAR. The filing index links above go to sec.gov.